All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-22448246
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 22448246 D67D
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
2 22448246 D67G
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
3 22448246 D67N
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
4 22448246 F116Y
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
5 22448246 F77L
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
6 22448246 G190A
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
7 22448246 G190G
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
8 22448246 I50V
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
9 22448246 I54L
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
10 22448246 I54V
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
11 22448246 K101E
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
12 22448246 K103K
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
13 22448246 K103N
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
14 22448246 K219E
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
15 22448246 K219K
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
16 22448246 K219N
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
17 22448246 K219Q
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
18 22448246 K219R
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
19 22448246 K70E
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
20 22448246 K70R
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
21 22448246 L210L
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
22 22448246 L210W
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
23 22448246 L24I
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
24 22448246 L76L
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
25 22448246 L76V
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
26 22448246 M184I
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
27 22448246 M184V
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
28 22448246 M41L
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
29 22448246 M41M
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
30 22448246 M46I
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
31 22448246 M46L
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
32 22448246 M46M
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
33 22448246 P225H
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
34 22448246 P225P
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
35 22448246 P225S
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
36 22448246 P225Y
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
37 22448246 Q151M
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
38 22448246 T215C
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
39 22448246 T215D
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
40 22448246 T215G
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
41 22448246 T215S
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
42 22448246 T215T
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
43 22448246 T215Y
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
44 22448246 V82A
PR
gag-pol
HIV Infections
D
G
S
C
L
T
View
45 22448246 Y115F
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
46 22448246 Y181C
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
47 22448246 Y181Y
RT
gag-pol
HIV Infections
D
G
S
C
L
T
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.